Technology and Industry Innovation
Through this survey, we are interested in understanding the broad impacts of innovation on productivity and worker behavior as well as the organizational mechanisms underlying such impact. A Business Model elucidates how an organization is linked to external stakeholders, and how it engages in economic exchanges with them to create value for all exchange partners. Business model innovation is the development of new, unique concepts supporting an organization's financial viability, including its mission, and the processes for bringing those concepts to fruition. The results of this study have important implications for an understanding of future shifts in innovation in firms. 
Objectives of Innovation
  • Information Sources for Innovation
  • Innovation Inhibitors
  • Support
  • Innovation Protection

SRITNE is in the process of conducting a systematic empirical study across multiple firms, which, in addressing the above research questions, will yield insights on the opportunities and critical success factors for innovations as well as the constraints faced by firms trying to innovate Using a combination of archival, field-level data analysis and qualitative interviews to address the above research questions. 
Technological Innovation and competitiveness of firms
Innovation is fundamental to the competitiveness of modern firms. The importance of innovative capabilities is especially pronounced in sectors where significant and pervasive digitization is creating new opportunities for product differentiation and enhancement, transforming business models and ushering in a new wave of competition from digital entrepreneurs and technology giants. Firms cannot ignore the imperative to innovate in this new disruptive business environment. However, that you cannot improve what you cannot measure also renders it imperative to continually measure innovation performance and capabilities of the firm. The innovation performance and potential of Novartis is measured at three levels: (a) Individual; (b) Team and (c) Organization.
  • Development of Innovation Index
  • Alignment of Business Goals & Assessment of Innovation interventions

To measure the innovation culture and effectiveness of Novartis, India SRITNE surveyed over 1200 executives in the Global Drug Development (GDD) organization , Novartis Limited , soliciting responses on their innovation strategy, culture, and metrics, amongst other parameters to understand the magnitude and nature of innovations in the firm and their contribution. We will complement the survey data with the company’s in-house employee engagement survey, detailed qualitative interviews with GDD leadership and archival firm data. Our assessment of the state of innovation in Novartis GDD assumes that several factors contribute to innovativeness of a firm, including selecting the right people for key initiatives, organizing project teams with the right mix of capabilities, establishing appropriate incentives, rewards and coordination mechanisms, driving external collaborations, and finally, creating an organizational culture that supports innovation. Understanding the interplay between these factors is crucial to assessing and designing the innovation trajectory of a firm. 
Research Papers
1Mani, Deepa; Desai, Amit"Global In-House Center Capability Maturity Index"2015
2Langer, Nishtha; Slaughter, S.A; Mukhopadhyay T."Practical Intelligence and Project Performance in Software Offshore Outsourcing: A Field Study"2014
3Nandakumar, Anand; Mani, Deepa"Teams and Effect on Innovation"2018
4Nandakumar, Anand; Mani, Deepa"Clusterpreneurship"2018
5Nandakumar, Anand; Mani, Deepa; Deuskar, Prachi"Angels and Crowds: Expanding Entrepreneurial Finance through Equity Crowdfunding"2018
6Nandakumar, Anand; Mani, Deepa; Deuskar, Prachi"An Empirical Analysis of the Labour Market Effects of Ridesharing Platforms"2018